Josh Arnold Investment Consultant »

Adaptimmune Therapeutics shares owned by Josh Arnold Investment Consultant

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAPY) shares owned by Josh Arnold Investment Consultant from 13F filings

Historical chart of Josh Arnold Investment Consultant investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Josh Arnold Investment Consultant consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Josh Arnold Investment Consultant

Quarter filed Position value Share count Share price at filing
2025-12-31 $38k 20k 1.89